Related Experiment Video
Updated: Jul 6, 2026
08:35
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
Published on: May 29, 2021
Semantics-enabled service discovery framework in the SIMDAT pharma grid.
Cangtao Qu1, Falk Zimmermann, Kai Kumpf
1IT Research Division, NEC Laboratories, Europe, NEC Europe Ltd., D-53757 Sankt Augustin, Germany. qu@it.neclab.edu
Summary
We developed a semantic service discovery framework for the SIMDAT Pharma Grid, enhancing biological data analysis. This framework uses ontologies and reasoning to improve in silico experiment workflows for drug discovery.
Area of Science:
- Bioinformatics
- Computational Biology
- Grid Computing
Background:
- Integrating diverse biological data and analysis services in Grid environments is challenging.
- Existing service discovery methods lack semantic understanding for complex biological workflows.
Purpose of the Study:
- To design and implement a semantics-enabled service discovery framework for the SIMDAT Pharma Grid.
- To enhance the integration and utilization of biological data and analysis services.
- To facilitate semi-automated in silico experiments for biologists.
Main Methods:
- Developed a biological domain ontology using Web Ontology Language (OWL)-Description Logic (DL).
- Annotated services using OWL Web Service Ontology (OWL-S).
- Implemented a semantic matchmaker leveraging ontology reasoning.
Main Results:
- Successfully integrated thousands of Grid-enabled biological data and analysis services.
- Demonstrated the framework's utility through a biological workflow case study (IXodus).
- Enabled more efficient and automated in silico experimentation.
Conclusions:
- The semantics-enabled framework significantly improves service discovery in biological Grid environments.
- Ontology-based reasoning enhances the automation of complex biological workflows.
- The SIMDAT Pharma Grid framework supports advanced process and product development in pharmaceutical research.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...